Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-4-8
pubmed:abstractText
RanBP2 is a nucleoporin with SUMO E3 ligase activity that functions in both nucleocytoplasmic transport and mitosis. However, the biological relevance of RanBP2 and the in vivo targets of its E3 ligase activity are unknown. Here we show that animals with low amounts of RanBP2 develop severe aneuploidy in the absence of overt transport defects. The main chromosome segregation defect in cells from these mice is anaphase-bridge formation. Topoisomerase IIalpha (Topo IIalpha), which decatenates sister centromeres prior to anaphase onset to prevent bridges, fails to accumulate at inner centromeres when RanBP2 levels are low. We find that RanBP2 sumoylates Topo IIalpha in mitosis and that this modification is required for its proper localization to inner centromeres. Furthermore, mice with low amounts of RanBP2 are highly sensitive to tumor formation. Together, these data identify RanBP2 as a chromosomal instability gene that regulates Topo IIalpha by sumoylation and suppresses tumorigenesis.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-10862613, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-11707590, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-11792325, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-11854305, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-12118244, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-12142524, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-12142526, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-12192048, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-12963708, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-14597774, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-14993277, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15062103, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15169916, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15378033, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15528356, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15613287, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15908946, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15933717, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-15999109, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-16204216, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-16355229, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-16887365, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-16943420, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-17046232, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-17069463, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-17183683, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-7775481, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-8408285, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-8620534, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-8978614, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-8978815, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-9019411, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394993-9858599
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1097-4172
pubmed:author
pubmed:issnType
Electronic
pubmed:day
4
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-15
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed-meshheading:18394993-Anaphase, pubmed-meshheading:18394993-Aneuploidy, pubmed-meshheading:18394993-Animals, pubmed-meshheading:18394993-Antigens, Neoplasm, pubmed-meshheading:18394993-Carcinogens, pubmed-meshheading:18394993-Centromere, pubmed-meshheading:18394993-DNA Topoisomerases, Type II, pubmed-meshheading:18394993-DNA-Binding Proteins, pubmed-meshheading:18394993-Fibroblasts, pubmed-meshheading:18394993-Mice, pubmed-meshheading:18394993-Mice, Knockout, pubmed-meshheading:18394993-Mitosis, pubmed-meshheading:18394993-Molecular Chaperones, pubmed-meshheading:18394993-Mutation, pubmed-meshheading:18394993-Neoplasms, pubmed-meshheading:18394993-Nuclear Pore Complex Proteins, pubmed-meshheading:18394993-Protein Structure, Tertiary, pubmed-meshheading:18394993-Small Ubiquitin-Related Modifier Proteins, pubmed-meshheading:18394993-Ubiquitin-Protein Ligases
pubmed:year
2008
pubmed:articleTitle
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
pubmed:affiliation
Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
pubmed:publicationType
Journal Article
More...